480 PLEASANT STREET, WATERTOWN, MA
Investor Presentation
Other Events, Press Release
Settlement Agreement with U.S. DOJ Regarding False Claims Act Violations
EyePoint, Inc. Increases Shares Authorized Under 2023 Long-Term Incentive Plan
Third Consecutive Positive DSMC Recommendation for Phase 3 Wet AMD Trials for DURAVYU™, Building Confidence Ahead of Mid-2026 Topline Data
Reports First Quarter 2026 Financial Results and Highlights Recent Corporate Developments
Q1
FY 2025
Q3
Q2
FY 2024
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
S-3ASR
Definitive Proxy Statement
Additional Proxy Materials
Amended Schedule 13G - Ownership Report
Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Free Writing Prospectus
Submission Upload